These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 9798551

  • 21. 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
    Büchner T, Hiddemann W, Berdel WE, Wörmann B, Schoch C, Fonatsch C, Löffler H, Haferlach T, Ludwig WD, Maschmeyer G, Staib P, Aul C, Gruneisen A, Lengfelder E, Frickhofen N, Kern W, Serve HL, Mesters RM, Sauerland MC, Heinecke A, German AML Cooperative Group.
    J Clin Oncol; 2003 Dec 15; 21(24):4496-504. PubMed ID: 14673036
    [Abstract] [Full Text] [Related]

  • 22. Concomitant hairy cell and acute myeloid leukemia.
    Rimner T, Went P, Tichelli A, Gratwohl A.
    Eur J Haematol; 2006 Jan 15; 76(1):86-8. PubMed ID: 16343277
    [Abstract] [Full Text] [Related]

  • 23. Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.
    Lange BJ, Dinndorf P, Smith FO, Arndt C, Barnard D, Feig S, Feusner J, Seibel N, Weiman M, Aplenc R, Gerbing R, Alonzo TA.
    J Clin Oncol; 2004 Jan 01; 22(1):150-6. PubMed ID: 14701777
    [Abstract] [Full Text] [Related]

  • 24. Nonmyeloablative allogeneic bone marrow transplantation for orbital granulocytic sarcoma associated with t(8;21)(q22;q22) in acute myeloid leukemia.
    Hung GY, Chiou TJ, Hsieh YL, Chen PM, Hwang B.
    Bone Marrow Transplant; 2002 Jan 01; 29(1):67-70. PubMed ID: 11840147
    [Abstract] [Full Text] [Related]

  • 25. Transient ring sideroblastosis in an allogeneic human bone marrow graft [proceedings].
    Rozman C, Granena A, Woessner S, Brugués R.
    Pathol Biol (Paris); 1978 Jan 01; 26(1):46. PubMed ID: 358086
    [No Abstract] [Full Text] [Related]

  • 26. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D, Hempel G, Fleischhack G, Schulz A, Boos J, Creutzig U.
    Klin Padiatr; 2002 Jan 01; 214(4):188-94. PubMed ID: 12165900
    [Abstract] [Full Text] [Related]

  • 27. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
    Bishop MR, Warkentin PI, Jackson JD, Bayever E, Iversen PL, Whalen VI, Lastovica J, Haines K, Kessinger A.
    Prog Clin Biol Res; 1994 Jan 01; 389():183-7. PubMed ID: 7700901
    [No Abstract] [Full Text] [Related]

  • 28. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
    Yang DH, Lee JJ, Mun YC, Shin HJ, Kim YK, Cho SH, Chung IJ, Seong CM, Kim HJ.
    Am J Hematol; 2007 Jan 01; 82(1):1-5. PubMed ID: 16986129
    [Abstract] [Full Text] [Related]

  • 29. The role of VP-16 in autologous bone marrow transplantation for acute myeloblastic leukemia.
    Parikh PM, Gelfand R, Gulati SC.
    J Assoc Physicians India; 1996 Apr 01; 44(4):252-4. PubMed ID: 9251396
    [No Abstract] [Full Text] [Related]

  • 30. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 01; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 31. Diffusion chamber cultures of bone marrow cells in refractory anemia with excess oil blasts (RAEB).
    Izzi T, Fontebuoni A, Talevi N, Lucarelli G.
    Haematologica; 1981 Oct 01; 66(5):570-8. PubMed ID: 6796466
    [No Abstract] [Full Text] [Related]

  • 32. Treatment of older patients with AML.
    Büchner T, Berdel WE, Wörmann B, Schoch C, Haferlach T, Schnittger S, Kern W, Aul C, Lengfelder E, Schumacher A, Reichle A, Staib P, Balleisen L, Eimermacher H, Grüneisen A, Rasche H, Sauerland MC, Heinecke A, Mesters RM, Serve HL, Kienast J, Hiddemann W.
    Crit Rev Oncol Hematol; 2005 Nov 01; 56(2):247-59. PubMed ID: 16246568
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Mild pre-transplant cardiomyopathy may not impair long-term quality of life after bone marrow transplantation.
    Nicolini B, Balduzzi A, Tagliabue A, Longoni D, Uderzo C, Galli MA.
    Bone Marrow Transplant; 2000 Feb 01; 25(3):335-6. PubMed ID: 10673709
    [Abstract] [Full Text] [Related]

  • 35. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia.
    Robertson MJ, Roy DC, Stone RM, Ritz J.
    Prog Clin Biol Res; 1994 Feb 01; 389():47-63. PubMed ID: 7700916
    [No Abstract] [Full Text] [Related]

  • 36. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
    Novitzky N, Thomas V, Abrahams L, du Toit C, McDonald A.
    Am J Hematol; 2004 Aug 01; 76(4):319-29. PubMed ID: 15282663
    [Abstract] [Full Text] [Related]

  • 37. Adult allogeneic bone marrow transplantation: initial experience in the University Hospital, Kuala Lumpur.
    Teh A, Bosco JJ, Leong KW, Saw MH, Menaka N, Devashanti P.
    Med J Malaysia; 1997 Mar 01; 52(1):26-32. PubMed ID: 10968050
    [Abstract] [Full Text] [Related]

  • 38. Chemotherapy of the myeloid leukaemias.
    Stuart J.
    J R Coll Physicians Lond; 1980 Jan 01; 14(1):36-41. PubMed ID: 7003128
    [Abstract] [Full Text] [Related]

  • 39. Allogeneic peripheral blood stem cell transplantation using a fludarabine-based low intensity conditioning regimen for malignant lymphoma.
    Nagler A, Slavin S, Varadi G, Naparstek E, Samuel S, Or R.
    Bone Marrow Transplant; 2000 May 01; 25(10):1021-8. PubMed ID: 10828860
    [Abstract] [Full Text] [Related]

  • 40. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
    Yavuz S, Paydas S, Disel U, Sahin B.
    Am J Ther; 2006 May 01; 13(5):389-93. PubMed ID: 16988532
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.